Ras-genes encode for proteins important for transmitting extracellular signals from the cytoplasm to the nucleus. In this study we investigated the impact of Ras on cell cycle progression after hepatectomy by using adenoviral vectors (adv) expressing b-galactosidase (b-gal), a dominantnegative (Ras N17) or a dominant-active (Ras 61L) form of H-Ras. Partial hepatectomy was performed in mice treated with the dierent adenoviruses and cell cycle progression was studied by analysing factors involved in cell cycle control during liver regeneration. After hepatectomy, adv Ras 61L increases DNA synthesis signi®cantly in comparison to the other treatment groups. Higher Ras activity results in an early increase of transcriptional active E2F-3, which is associated with higher cyclin E, but almost unchanged cyclin D protein expression. However, Northern blot analysis and cyclin E promoter experiments indicate that, besides transcriptional mechanisms also post-transcriptional mechanisms are involved in regulating cyclin E protein expression after partial hepatectomy in mice treated with adv Ras 61L.
Introduction
The Ras genes (H-Ras, N-Ras and K-Ras) encode for 188 ± 189 amino acid proteins located at the inner surface of the plasma membrane (Boguski and McCormick, 1993) . Ras proteins serve as a binary molecular switch mediating receptor-dependent signals. Wild-type Ras proteins are activated transiently via a guanine nucleotide exchange mechanism through extracellular stimuli involved in cell growth, dierentiation and apoptosis (Schlessinger, 1993; Vaux and Korsmeyer, 1999) . After ligand binding, as for example shown for the EGF-or HGF-receptor, tyrosine kinases are activated and create binding sites for Src homology 2 (SH2) and/or phosphotyrosil binding (PTB) domains that become auto-phosphorylated. Phosphorylation of SH2 domains results in the interaction with Grb2 and its association partner SOS which provides the direct link to a transient elevation of the active GTP-bound form of Ras (Boguski and McCormick, 1993; Campbell et al., 1998) .
After activation of Ras there is clear evidence that Raf-1 plays an important role in mediating several of the downstream eects of Ras. The GTP-bound form of Ras binds to and thus activates the normally cytoplasmatic Raf-1 serine/threonine kinase. This event triggers a signaling cascade which ®rst phosphorylates the two MAPK kinases (Mitogen activated kinase kinases, also called MEK1 and 2) and eventually the two MAPKs ERK 1 and ERK 2. After phosphorylation, ERK 1 and 2 translocate to the nucleus where they phosphorylate and activate several substrates essential for mediating Ras-dependent mechanisms (Downward, 1998; Moodie and Wolfman, 1994; Morrison and Cutler, 1997, Treisman, 1996) . Besides activating the Raf-1-dependent downstream signals, additional pathways directly or indirectly diverge from the GTP-bound Ras molecule. Examples for molecules involved in this regulation are the phospatidylinositol 3 (OH) kinase (PI(3)K), the Ral guanine nucleotide dissociation stimulator (RalGDS), the mitogen-activated protein kinase kinase 1 (MEKK1) or the Ras interaction/ interference gene 1 (Rin1) (Campbell et al., 1998) .
Mutational changes introduced or derived from tumors in the Ras open reading frame (ORF) indicated that the activity of Ras could be modulated. While the mutation Ras N17 results in a dominant-negative form of Ras, dierent mutations as shown for H-Ras 12V or H-Ras L61 are dominant active and hyperstimulate the downstream signaling cascades (Yang et al., 1998; Leone et al., 1997) . Experiments with these mutated forms of Ras showed that Ras directly in¯uences cell cycle progression and proliferation of cells derived from dierent organs. Most of these experiments were performed in vitro, and there is only limited information obtained by in vivo studies (Yang et al., 1998; Leone et al., 1997; Takuwa and Takuwa, 1997; Hitomi and Stacey, 1999; Winston et al., 1996) .
After injury and loss of viable tissue the liver has the capacity to restore liver mass by cell proliferation (Michalopoulos and DeFrances, 1997) . In contrast, normal hepatocytes have a long life span and rarely divide under physiological conditions. After surgical removal of two-thirds of the liver (Higgins and Anderson, 1931) , DNA synthesis starts after 24 to 48 h depending on the animal investigated. In the period before the start of DNA synthesis, factors have been de®ned which are essential to prime hepatocytes for cell proliferation. For several growth factors it has been shown that they directly stimulate hepatocyte proliferation. Prominent ones are hepatocyte growth factor (HGF) and epidermal growth factor (EGF). Both growth factors activate Ras-dependent signaling cascades (Tulasne et al., 1999; Egan and Weinberg, 1993) .
However, the ultimate mechanisms linking Rasdependent signals to cell cycle progression of hepatocytes in vivo after hepatectomy are only poorly understood. Therefore, we investigated the impact of Ras on the cell cycle machinery after partial hepatectomy in hepatocytes. In order to have a better understanding of the mechanisms that are involved in this process, we used adenoviral vectors expressing a dominant-negative or a dominant-active form of Ras and a b-gal control virus. Our results show that overstimulating Ras has a direct impact on hepatocyte proliferation and indicate that the primary target of Ras during liver regeneration is to modulate the activity of the Cyclin E/CDK2 complex. Thus our study provides new insights into the molecular mechanisms activated in hepatocytes after partial hepatectomy.
Results

The Ras adenoviruses are functional active in hepatoma cells
To investigate the role of Ras in liver regeneration after two-thirds hepatectomy, adenoviruses expressing a dominant-active (adv Ras 61L) and a dominantnegative (adv Ras N17) form of Ras were included in this study. As a control virus, a b-galactosidase expressing adenovirus ± adv b-gal ± was used. As the relevance on Ras activity of either the adenoviral infection itself or the dierent Ras mutant viruses in liver cells was unknown, we ®rst determined the impact of these viruses on Ras activity in HepG2 hepatoma cells.
A main downstream target of Ras signaling is phosphorylation of ERK 1 and 2 (Downward, 1998; Moodie and Wolfman, 1994; Morrison and Cutler, 1997; Treisman, 1996) . We studied ERK kinase activity in cells treated with one of the adenoviruses or the carrier solution alone (Figure 1a,b) . ERK kinase assays were performed with nuclear extracts 24 h after infection. The adv b-gal increased ERK kinase activity 2.5-fold compared to cells treated with the carrier solution. In contrast, infection of adv Ras N17 resulted in a reduction of ERK kinase activity compared to adv b-gal and was only 30% above the activity of carrier solution treated cells. In cells treated with adv Ras 61L ERK kinase activity was increased sevenfold.
The changes in ERK kinase activity of the four conditions were con®rmed by Western blot analysis using antibodies, which detect phosphorylated ERK 1 and 2 (anti-phospho ERK, Figure 1c , upper panel). Additionally, Western blot analysis was performed using an anti-Ras antibody. These experiments showed that with adv Ras 61L there was a ®vefold increase in Ras expression while with adv Ras N17 the increase was only twofold (data not shown). These results together with the ERK kinase assays indicated that using the same Pfu the Ras N17 constructs was the less eective vector in modulating ERK kinase activity compared to adv Ras 61L.
Activation of Ras could in¯uence the expression level of ERK, which may explain these ®ndings. To exclude this possibility, ERK protein expression was studied using an anti-ERK 2 antibody (Figure 1c , lower panel). These experiments suggest that the dierent adenoviruses modulate ERK kinase activity without changing ERK expression in HepG2 cells.
To further test the functional activity of adv Ras N17 as a dominant-negative construct, we performed co-infection experiments of HepG2 cells using the two Ras adenoviruses. Additionally the b-gal virus was added to keep the virus concentration constant throughout the experiments. This study showed that adv Ras N17 was able to inhibit the eect of adv Ras 61L on ERK activity ( Figure 1d ). As a loading control, membranes were incubated with an anti-a-Tubulin antibody (Figure 1d ).
The Ras adenoviruses modulate ERK activity in vivo Next, we addressed the question of how eectively Ras activity can be manipulated in hepatocytes in vivo. Dose-and time-kinetic experiments were performed with increasing amounts of the adv b-gal to analyse the rate of infected hepatocytes and the eect on transaminases as a parameter of liver toxicity. 1.6610 9 Pfu of virus reproducibly infected at least 80% of the hepatocytes. The maximal expression level was found between 12 and 72 h after the infection ( Figure 2a) . As a consequence the adenoviral infection was performed 24 h before two-thirds hepatectomy. Nuclear extracts were prepared from the liver remnants at dierent time points after surgery. The same Pfu doses of adv Ras N17 and adv Ras 61L were used as determined for adv b-gal.
In parallel to the time points when liver nuclear extracts were prepared, blood was taken to measure transaminase serum levels (Figure 2b ). No signi®cant dierences were found between all subgroups. In all the four groups a maximum in transaminase levels was detected 24 h after hepatectomy. At later time points transaminases decreased in all groups indicating that the transient increase in transaminases was related to liver resection. Changes in transaminases were not found in sham treated animals (data not shown).
The liver nuclear extracts were used to analyse ERK phosphorylation before and at time points after hepatectomy by Western blot analysis using the antiphospho ERK antibody. In animals treated with the Figure 2 After adenoviral infection of the liver and hepatectomy no increase in liver toxicity was found compared to control treated animals. (a) A dose of 1.6610 9 Pfu adv b-gal was injected per tail vein into NMRI mice. At dierent time points after injection, b-gal staining of the livers was performed. At time points between 12 to 72 h, 480% of hepatocytes were infected as shown. (b) Blood was obtained at dierent time points after hepatectomy. Serum was prepared and transaminases were determined. The time kinetic of transaminase levels for adv bgal, adv Ras N17, adv Ras 61L and control treated animals are shown. The symbols representing the dierent treatment groups are indicated Figure 1 The adv Ras 61L virus increases ERK kinase activity in HepG2 hepatoma cells. HepG2 cells were infected with adv bgal, Ras N17 or Ras 61L at a MOI of 100. In control treated cells, only the carrier solution was added. Nuclear extracts were prepared 24 h after infection. (a) ERK kinase assays were performed with HepG2 nuclear extracts derived from the dierent conditions as indicated using myelin basic protein (MBP) as a substrate. The kinase reaction was separated on a 12.5% SDSpolyacrylamide gel and the phosphorylated substrate was visualized by autoradiography. The position of MBP is shown. (b) Quanti®cation of the phosphorylated MBP was performed using a phospho Imager. The relative signal of the control treated cells was set to 1 and the relative changes which were found in nuclear extracts derived from adv b-gal, Ras N17 or Ras 61L infected HepG2 cells were calculated accordingly. (c) 10 mg nuclear extracts derived from adv b-gal; adv Ras N17, adv Ras 61L and control treated cells were used for Western blot analysis using an anti-phospho ERK (upper panel) or an anti-ERK 2 (lower panel) antibody. The positions of phosphorylated ERK 1 and 2 or ERK are shown by arrows. (d) Cells were infected with adv-b-gal, adv Ras N17 and adv Ras 61L at a total MOI of 100. The dierent viral constructs were used in a concentration as indicated in the legend. Each plus stands for a de®ned part of the total viral load. Twenty-four hours after infection the cells were harvested and activation of ERK1 and ERK2 was tested by Western blot using a Phospho-ERK speci®c antibody. In order to ensure equal protein loading, an antibody directed against aTubulin was used carrier solution alone an increase in phospho-ERK 1 and 2 was observed 48 h after hepatectomy, and the same signal intensity was evident after 72 h ( Figure  3a ). In the adv b-gal group a slight increase in ERK phosphorylation was ®rst found after 24 h and maximal levels were present 48 h after hepatectomy. After 72 h the intensity of the signal decreased again (Figure 3b) .
In animals infected with the Ras expressing viruses, a shift in the ERK phosphorylation kinetic was especially obvious in the adv Ras 61L treated mice. Strong phosphorylation of ERK 1 and 2 was found 24 h after adenoviral infection before surgery ( Figure  3c ). An increase in ERK phosphorylation was detected during the 72 h observation period. A maximum in phospho-ERK expression was obvious 12 h after hepatectomy.
In the adv Ras N17 group, stronger phospho ERK 1 and 2 signals were found 24 h after surgery. A further increase was detected at later time points, and maximal ERK 1 and 2 phosphorylation was obvious after 72 h (Figure 3d ).
The Ras adenoviruses have only a minor effect on JNK activity
Adv Ras 61L had a strong eect on ERK phosphorylation. However Ras may also activate other related MAP Kinases (Campbell et al., 1998) . Therefore we studied the eect of the Ras adenoviruses on Jun kinase (JNK) activity. We ®rst investigated the eect of the dierent adenoviruses on JNK activity in HepG2 cells by determining the level of c-Jun phosphorylation (phospho c-Jun). A 50% increase in phospho c-Jun expression was found 24 h after treating cells with adv b-gal (Figure 4a ). After infection of the adv Ras 61L phospho c-Jun levels were 100% higher compared to the untreated control. In contrast, adv Ras N17 had no signi®cant eect on phospho c-Jun levels compared to untreated cells (Figure 4a) .
Additionally phospho c-Jun expression was determined in vivo before and after hepatectomy in the adv b-gal and adv Ras 61L group. Before hepatectomy there was no signi®cant dierence between the two groups in phospho c-Jun expression (Figure 4b ). Also, Figure 4 JNK activation after adenoviral infection. (a) HepG2 cells were infected with the dierent viral constructs or carrier solution alone with an MOI of 100. Twenty-four hours after infection, cells were harvested and activation of Jun-Kinase was tested by Western blot analysis using an antibody that speci®cally binds to phosphorylated c-Jun. Equal loading was ensured by using the a-Tubulin antibody. In (b), the antibody directed against phosphorylated c-Jun was used for Western blot analysis with 10 mg of nuclear protein extracts per lane derived from dierent time-points after hepatectomy as indicated Figure 3 Adv Ras 61L increases ERK phosphorylation before and after hepatectomy. NMRI mice were treated with the carrier solution (a) or 1.6610 9 Pfu of adv b-gal (b), adv Ras 61L (c) or adv Ras N17 (d). Liver nuclear extracts were prepared 24 h after treatment directly before hepatectomy or at dierent time points after hepatectomy as indicated. Ten mg of liver nuclear extracts derived from adv b-gal, adv Ras N17, adv Ras 61L and control treated mice were used for Western blot analysis using an antiphospho-ERK antibody. The position of phospho ERK 1 and 2 are shown after hepatectomy there was no signi®cant dierence in c-Jun phosphorylation between the two groups ( Figure  4b ). Thus, the in vitro and in vivo ERK and phospho cJun experiments demonstrated that the adv Ras 61L construct had a strong eect on ERK but only a minor eect on JNK activity.
Differences in DNA synthesis between the groups after hepatectomy DNA synthesis was studied by BrdU staining ( Figure  5 ). After hepatectomy, BrdU labeling continuously increased in the adv Ras 61L group and was signi®cantly higher compared to the carrier control and the adv Ras N17 group. Twenty-four hours after hepatectomy, DNA synthesis was fourfold and 2.5-fold higher compared to the carrier control and adv Ras N17 group respectively. These dierences were even more prominent between the adv Ras 61L and Ras N17 group around the central vein, where the maximum of adenoviral infection was found in NMRI mice. A 30% higher rate of DNA synthesis was also obvious in the adv Ras 61L treated animals compared to the adv b-gal group.
After 48 h, DNA synthesis further increased in all groups and was highest in the adv Ras 61L group. At this time point there was also an increase in BrdU staining in the adv Ras N17 group in the region of maximal adenoviral infection.
Infection with Ras 61L increases cyclin E expression after hepatectomy
In ®broblasts, there is evidence that Ras directly stimulates Cyclin D gene transcription and thus induces cell cycle progression (Gille and Downward, 1999; Fan and Bertino, 1997) . Western blot analysis was performed with an anti-cyclin D antibody. Only a slight increase in expression of cyclin D1 and D2 was detected in the carrier solution control group after hepatectomy. Similar expression levels were found in all the other groups and only minor variations in cyclin D expression were obvious after hepatectomy ( Figure  6a and data not shown).
As high cyclin D expression was already observed before hepatectomy, one of the next targets during cell cycle progression is cyclin E. An increase in cyclin E expression was detected in animals treated with the carrier solution 24 and 48 h after hepatectomy. This increase was not found in sham treated mice (data not shown). Cyclin E expression decreased after 72 h ( Figure 6b ).
In the adv b-gal group, the same time-kinetic in cyclin E expression was found as shown for carrier solution treated animals. However, cyclin E signals were more than ®vefold stronger, indicating that adv bgal increased cyclin E protein levels without changing its time course compared to controls (Figure 6b ). Similar results shown for adv b-gal were found with adv Ras N17 (data not shown).
In contrast, in the adv Ras 61L group higher cyclin E protein levels were present before surgery and a continuous strong increase was obvious after hepatectomy. Maximal cyclin E expression was evident 24 h after hepatectomy exceeding the level more than 20-fold compared to the control group (Figure 6b ). This strong increase was not found in adv Ras 61L treated animals after sham surgery (data not shown).
An active cyclin E/CDK2 complex is important to enter S phase and thus to stimulate cyclin A expression. In the control group, cyclin A followed cyclin E expression and was strongly detected in liver nuclear extracts 48 and 72 h after hepatectomy ( Figure  6c ). In the adv b-gal treated animals, cyclin A was ®rst seen after 24 h, while maximum levels were obvious at the 48 h time point. In the adv Ras 61L group, cyclin A also followed cyclin E expression. A signi®cant increase was ®rst found after 2 h and maximal levels were detected at 24 and 48 h after hepatectomy. Adv Ras 61L increases DNA synthesis after hepatectomy. BrdU staining of liver sections was performed at dierent time points before and after hepatectomy. Two hours before sacri®cing the animals, 30 mg/g mice of BrdU were injected i.p. Animals either treated with the carrier solution, the adv b-gal, adv Ras N17 or adv Ras 61L were included. (a) For statistical analysis, the maximal amount of BrdU-positive hepatocytes as found in the adv Ras 61L group 48 h after hepatectomy was set to 100%. All other groups and time points were calculated accordingly. (b) Representative stainings of the animals treated with adv b-gal after 24 and 48 h, adv Ras N17 after 24 h and adv Ras 61L after 48 h are depicted
HGF stimulates ERK phosphorylation and cyclin E expression after hepatectomy
To ensure that the shown correlation between higher ERK activity and an increase in cyclin E expression was not caused by eects mediated by the adenoviral infection itself we performed HGF stimulation experiments after and before hepatectomy. HGF is a known stimulus of ERK (Brenner, 1998 ) and therefore we studied ERK phosphorylation and cyclin E expression in these animals. In the control treated animals, higher cyclin E expression was ®rst detected 24 h after hepatectomy (see Figure  6b ). Therefore we studied if HGF stimulation had an eect on ERK activity and cyclin E expression 24 h after hepatectomy. We stimulated the animals with 2 mg of HGF or in the control group with 0.9% NaCl every 6 h. One hour after the last stimulation nuclear extracts were prepared and phospho ERK and cyclin E expression was determined (Figure 7a ).
In the control group, there was a slight increase in phospho ERK 1+2 expression 24 h after hepatectomy compared to the time point before hepatectomy. In the HGF-stimulated animals the increase in ERK 1+2 expression was more pronounced exceeding the expression of animals before hepatectomy more than sixfold and of the control group at the same time points more than threefold (Figure 7b, upper panel) .
Western blot analysis using a cyclin E antibody revealed a 2.5-fold higher expression of cyclin E in the HGF stimulated animals compared to the control group 24 h after hepatectomy (Figure 7b , lower panel). Therefore these experiments ± as shown before with adv Ras 61L ± indicated a correlation between higher ERK activity and cyclin E expression after hepatectomy. Adv Ras 61L stimulates CDK2 activity By interacting with CDK2, cyclin E builds an active kinase complex, which phosphorylates several targets important for entering S phase. Distinct inhibitors like p21 and p27 may control its activity. To evaluate these dierent regulatory pathways, we directly measured CDK2 activity by kinase assay using liver nuclear extracts.
In animals treated with the carrier solution, an increase in CDK2 activity was found 48 h after hepatectomy (Figure 8a ). In adv b-gal treated animals, a slight increase in CDK2 activity was evident after 24 h and maximal levels were found 48 h after hepatectomy. In contrast, in the adv Ras 61L group, there was a clear increase in CDK2 activity 2 h after hepatectomy. CDK2 activity gradually increased, and maximal levels were found after 48 h. However, at this time point the maximum level in CDK2 activity was lower compared to adv b-gal treated animals ( Figure  8b ,c).
Adv Ras L61 changes the time kinetic in E2F DNA binding
Our results show that adv Ras 61L strongly stimulates cyclin E expression and results in a more active CDK2 complex directly after hepatectomy. As adv b-gal did not show this change in timing, these results suggest that they were directly related to Ras stimulation. Thus we studied dierences in regulating cyclin E expression between the adv Ras 61L and b-gal group.
One element of stimulation of cyclin E transcription after hepatectomy is increased binding of E2F (Botz et al., 1996; Trautwein et al., 1999) . In the adv b-gal group gel shift experiments using a consensus E2F oligonucleotide revealed an increase in DNA binding of free E2F 48 h after hepatectomy ( Figure  9a ). In contrast, in the adv Ras 61L group free E2F complex formation was found after 2 h and free E2F DNA binding was present for up to 72 h after hepatectomy (Figure 9b ). The speci®city of complex formation was con®rmed by competition experiments (Figure 9c ).
To exclude that these results were caused by higher E2F protein expression, Western blot analysis was performed using an anti-E2F-3 antibody in order to detect the most abundant E2F form in the liver. During the ®rst 24 h after hepatectomy, similar E2F-3 expression levels were present in the two groups (Figure 9d ).
Adv Ras 61L modulates cyclin E transcription
Cyclin E mRNA levels were analysed by Northern blot analysis at dierent time points before and after hepatectomy. In the adv b-gal group no cyclin E mRNA was detected before hepatectomy. Signals for cyclin E were found 24 and 48 h after hepatectomy (Figure 10a ). In contrast, in the adv Ras 61L group the ®rst cyclin E signal was seen 6 h after hepatectomy. Cyclin E mRNA levels gradually increased, and maximal expression was obvious 48 h after hepatectomy. These results indicate that Ras directly stimulates cyclin E mRNA expression (Figure 8b ). However these data suggested that posttranscriptional mechanism might also contribute to higher cyclin E protein expression as maximal levels were found after 24 h, while cyclin E mRNA levels peaked 48 h after hepatectomy.
To further investigate the impact of activated Ras on Cyclin E transcription, a promoter construct with the cyclin E promoter linked to a luciferase reporter was transfected in HepG2 cells (Figure 10b ). Cells were infected with the dierent adenoviruses or treated with the carrier solution for 24 h. Adv b-gal which itself Figure 8 Adv Ras 61L results in an early activation of CDK2 activity after hepatectomy. CDK2 activity was measured before and after hepatectomy in animals treated with carrier control (a), adv b-gal (b) or adv Ras 61L (c). Immunoprecipitated CDK2 derived from 20 mg liver nuclear extracts was incubated in a kinase assay with Histone H1 as substrate. The kinase reaction was separated on a 12.5% SDS-polyacrylamide gel and the phosphorylated substrate was visualized by autoradiography. The position of phosphorylated Histone H 1 is indicated activates Ras (see Figure 1 ) stimulated luciferase activity 2.5-fold, while with adv Ras 61L a fourfold increase was found compared to the carrier control (Figure 10b ). Using adv Ras 17N resulted only in a minor reduction of luciferase activity compared to adv b-gal.
Adv Ras 61L decreases cyclin E phosphorylation
The Northern blot results and the transfection experiments with the cyclin E promoter constructs indicated that, besides a direct increase in cyclin E transcription, post-transcriptional mechanisms may Figure 9 Adv Ras 61L leads to an earlier activation of transcriptional active E2F. Gel shift experiments were performed with a 32 P-labeled E2F consensus oligonucleotide and nuclear extracts prepared from either adv b-gal (a) or adv Ras 61L (b) treated mice at the time points indicated. Competition experiments were performed (c) to show the speci®city of complex formation. For competition experiments, nuclear extracts from the adv b-gal treated animals were used 48 h after hepatectomy (see a, lane 7). Increasing amounts of cold E2F consensus oligonucleotide were added to the binding reaction. In (d), the nuclear expression of E2F-3 before and after hepatectomy was studied by Western blot analysis using an anti-E2F-3 antibody also be involved in regulating cyclin E protein expression. This became evident 24 h after hepatectomy, when maximal cyclin E protein expression was obvious, while the maximal cyclin E mRNA level was found 48 h after hepatectomy. During liver regeneration there is a rapid decrease in cyclin E expression after passing the G1/S-phase checkpoint . Phosphorylation of cyclin E results in its degradation by the ubiquitinin/proteasome system (Won and Reed, 1996; Dealy et al., 1999; Wang et al., 1999) . Therefore, phosphorylation of cyclin E may control its half-life.
In order to test this mechanism in our model, the cyclin E mRNA was ampli®ed by RT ± PCR and cloned in frame in a GST expression vector. The correct insert was veri®ed by sequencing, and the resulting GST-cyclin E fusion protein was quanti®ed by Coomassie blue staining. The speci®city of the GSTcyclin E fusion protein was con®rmed by Western blot analysis (Figure 11a) .
A cyclin E kinase assay was performed using the GST-cyclin E fusion protein as a substrate ( Figure  11b ). The protein was incubated with liver nuclear extracts derived from the adv b-gal and adv Ras 61L group before and at time points after hepatectomy. These experiments showed that, already before hepatectomy, decreased cyclin E phosphorylation was evident in the adv Ras 61L compared to the adv bgal group. At the 6-h time point, cyclin E phosphorylation further decreased in adv Ras 61L treated animals, while it was slightly higher in the adv b-gal group compared to the time point before hepatectomy. After 12 h, cyclin E phosphorylation was still signi®cantly stronger in the adv b-gal group compared to the Ras 61L group. In contrast, after 24 h, cyclin E phosphorylation decreased in the adv b-gal and increased in the adv Ras 61L group. This observation coincides with the time point when cyclin E expression decreases in the adv Ras 61L group, while cyclin E mRNA levels are still increasing to maximal levels 48 h after hepatectomy. 
Discussion
In this study, we investigated the impact of Ras on cell cycle progression after partial hepatectomy in mice. Dierent adenoviral constructs were used in this analysis, expressing either the b-galactosidase gene as control adv, dominant-negative Ras N17 or dominantactive Ras 61L. Changes in Ras activity induced by the three adenoviruses were ®rst studied in hepatoma cells. Interestingly, the adv b-gal itself stimulated Ras as measured indirectly by ERK kinase assay. The adv Ras N17 reduced, while adv Ras 61L strongly increased ERK kinase activity.
Before starting with the in vivo hepatectomy experiments, extensive work was performed to titrate the exact adenoviral dose for transgene expression in the liver. High doses resulted in liver toxicity, while with low doses only a minor amount of hepatocytes could be infected. 1.6610 9 Pfu adv b-gal infected at least 80% of the hepatocytes. At this concentration, no signi®cant increase in transaminases was found 24 h after infection. A dose-kinetic approach for adenoviral transfer was recently reported in rhesus macaques, where higher doses also resulted in liver toxicity (Lozier et al., 1999) . Liver damage after adenoviral gene transfer has been linked to immune mediated mechanisms through the TNF receptor and Fas system (KuÈ hnel et al., 2000; Hayder et al., 1999) .
In vivo, 24 h after infection of the liver no dierences in ERK phosphorylation between the carrier control and the adv b-gal or the adv Ras N17 were found. A signi®cant increase of ERK-phosphorylation in these three groups was only detected 24 h and later after hepatectomy. In contrast, adv Ras 61L resulted in strong ERK phosphorylation already before and also after hepatectomy.
Two groups recently studied the role of ERK phosphorylation after partial hepatectomy (Spector et al., 1997; Talarmin et al., 1999) . In both studies, rats were used. Spector et al. (1997) used freshly isolated hepatocytes directly after partial hepatectomy, which makes these results dicult to compare with our present analysis. In contrast, Talarmin et al. (1999) found two peaks in ERK phosphorylation 1 to 4 h and 10.5 h after hepatectomy. DNA synthesis started 18 h after hepatectomy. In the carrier control group of the present study, an increase in DNA synthesis was ®rst found 48 h after hepatectomy. Thus, the time intervals for cell cycle progression between rats and mice are dierent. However, the prolonged early increase in ERK phosphorylation 1 to 4 h after hepatectomy as found by Talarmin et al. (1999) was not obvious in this study. Hence this early peak in ERK phosphorylation after hepatectomy might be less prominent in mice.
Stronger ERK activation in the Ras adv 61L group correlated with an earlier start of DNA synthesis after hepatectomy. A 2.5-fold stronger increase in DNA synthesis ± as measured by BrdU incorporation ± was obvious 24 h after hepatectomy compared to the Ras N17 group, and also in comparison to the adv b-gal group a signi®cant increase in DNA synthesis was evident. Additionally these observations seemed even more prominent when the areas of maximal viral infection were analysed especially in the adv Ras N17 group. In this study, at the 24 h time point few BrdU positive cells were found in the areas with the maximal adenoviral infection. In contrast, after 48 h, there was also a strong increase in BrdU staining in these areas indicating that the inhibitory eect of adv Ras N17 could be overwhelmed by naturally occurring stimuli activated after hepatectomy. This may also explain the continuous increase in ERK phosphorylation 24 to 72 h after hepatectomy in the adv Ras N17 group that was not found in the adv b-gal and the carrier control group. The observation that there was no stronger eect on inhibiting cell cycle progression after hepatectomy with adv Ras N17 is best explained through the relatively low expression level of the transgene in this construct. However the results using both adenoviruses indicated that Ras activation has a direct impact on the start and the maximal level of DNA synthesis after two-thirds hepatectomy. Thus, in further experiments we investigated the mechanisms that mediate these dierences in vivo.
We ®rst analysed the dierent cyclins important for driving hepatocytes from G0-into S phase. No Figure 11 Lower cyclin E phosphorylation was found before and early after hepatectomy in the adv Ras 61L group. Western blot analysis of the GST-cyclin E fusion protein was performed using an anti-cyclin E antibody (a). The position of the cyclin E fusion protein is indicated. A cyclin E phosphorylation assay was performed using liver nuclear extracts at the time points indicated with GST-cyclin E as a substrate (b). The kinase reaction product was separated on a 12.5% SDS-polyacrylamide gel and the phosphorylated substrate was visualized. The position of phosphorylated GST-cyclin E is shown signi®cant changes in cyclin D expression between the groups were found. These results indicate that cyclin D is not exclusively the primary target of Ras in liver cells as it is in ®broblasts or other cell culture systems, where overexpression of activated Ras led to a strong induction of cyclin D expression. As shown in rats , on the protein level, there are only minor dierences in cyclin D expression after hepatectomy. Talarmin et al. (1999) found an increase in cyclin D1 mRNA expression 12 to 16 h after hepatectomy in rats. As DNA synthesis started after 18 h in these animals, the increase in cyclin D protein expression would directly start before the G1/S phase restriction point where also higher cyclin E expression would be expected. However, experiments investigating cyclin E expression were not included in their analysis. In mice Greenbaum et al. (1998) investigated cyclin D expression. They found an increase in cyclin D expression 36 h after hepatectomy while higher cyclin E levels were ®rst evident after 16 h. Therefore their results would also indicate that cyclin E and not cyclin D is the primarily activated G1-cyclin after hepatectomy in mice.
In this analysis, dierences in cyclin E expression were obvious between the groups. In the carrier control, the adv b-gal and the Ras N17 group, cyclin E expression was ®rst found 24 h after hepatectomy and lasted up to 72 h ± depending on the group. Timing of cyclin E expression and the increase in ERK phosphorylation after hepatectomy correlated with each other. However, when cyclin E expression was compared between the carrier control and the adv b-gal or the adv Ras N17 treated animals, a signi®cant increase was found in animals treated with either of the two adenoviruses. As there was no signi®cant dierence in the cyclin E expression level between the adv bgal and the Ras N17 group, the changes are most likely not explained by the dierences in transgene expression, but by the adenoviral infection itself. There are several reports showing that adenoviruses directly in¯uence cell cycle progression by interfering with the E2F complex (Fattaey et al., 1993; Zamanian and La Thangue, 1992; Bandara and La Thangue, 1991) . However, these results were linked to the adenoviral protein E1A deleted in the recombinant adenoviruses used in this study. Therefore, these results indicate that adenoviral proteins other than E1A most likely interfere with protein expression of cyclin E, at least in hepatocytes during cell cycle progression after hepatectomy.
A dierent time kinetic in cyclin E expression was found in the adv Ras 61L group. Increased cyclin E expression was evident already before hepatectomy, and a dramatic increase was found for up to 24 h after hepatectomy. The cyclin E expression level and the time course was dierent compared to the other two adv groups, which implies that this strong increase was related to Ras activation.
Earlier results demonstrated that Ras induces Cyclin E transcription via E2F activation (Leone et al., 1997) . In the Ras 61L group an increase in free E2F was found 2 h after hepatectomy. Stronger and early E2F DNA binding ± a well described eect of pocket protein activation ± is therefore an obvious result of Ras activation in the regenerating liver and seems to contribute at least in part to cyclin E expression in this system.
A slight increase in cyclin E mRNA levels was ®rst evident after 6 h. However, a dramatic increase was ®rst prominent after 48 h. At this time point, Cyclin E protein expression was decreased compared to the maximal level found 24 h after hepatectomy. The time kinetic of cyclin E expression after hepatectomy and experiments using cyclin E promoter constructs suggested additional posttranscriptional mechanisms, which contribute to the regulation of cyclin E expression. Cyclin E stability is controlled by phosphorylation which links its degradation to the ubiquitinin/proteasome system (Won and Reed, 1996; Dealy et al., 1999; Wang et al., 1999) . The phosphorylation status of cyclin E was studied using a GSTcyclin E fusion protein as substrate for a kinase assay in order to examine if there was any change in the activity of a cyclin E directed kinase complex in the protein-extracts derived from in vivo experiments. These results showed that there was less phosphorylation of the GST-Cyclin E-construct early after hepatectomy in the adv Ras 61L group, when the maximal increase in cyclin E protein expression was evident.
Earlier reports demonstrated that in vitro phosphorylation of human cyclin E at threonine 380 results in binding of Cul-3, which results in its ubiquitination and degradation (Won and Reed, 1996; Singer et al., 1999) . On the other hand it has been shown that activation of Ras can stabilize myc by inhibition of its ubiquitination by the ubiquitinin/proteasome system (Sears et al., 1999) . Therefore, it is possible that besides an increase in gene transcription also lower phosphorylation and degradation of cyclin E might contribute to the early protein expression of cyclin E in the activated Ras group. In our experimental system, there is no absolute proof which role the Ras 61L transgene or the adenoviral infection plays for the posttranscriptional regulation of cyclin E. However, the increase in cyclin E expression is several fold higher compared to the other viral groups. These results suggest that Ras 61L stimulates the increase in cyclin E expression on a posttranscriptional level after hepatectomy. Additionally, the HGF stimulation experiments indicated that there is direct correlation between Ras-activation and an increase in cyclin E expression.
The mechanisms resulting in stronger DNA synthesis during the ®rst 24 h after hepatectomy were further investigated by measuring CDK2 activity. In the adv Ras 61L group CDK2 activity was higher 2 h after hepatectomy and increased until up to 48 h. This was in contrast to the control groups where CDK2 activity was only detectable 48 h after hepatectomy. The eect on CDK2 activity in the adv Ras 61L group was less dramatic compared to the strong increase in cyclin E expression. However, CDK2 activity correlated better with the amount of hepatocytes which progressed into S phase as evidenced by cyclin A expression and BrdU staining in the adv Ras 61L group. Therefore, besides increasing Ras activity and cyclin E expression, additional mechanisms are relevant to stimulate hepatocyte proliferation after hepatectomy. Earlier in vitro results (Leone et al., 1997) demonstrated that cmyc and Ras are required to achieve a maximal eect on DNA synthesis.
Besides the mechanisms directly stimulating DNA synthesis of hepatocytes after hepatectomy, there is evidence that also a modulation of the extracellular matrix is important for the start of DNA synthesis (Rudolph et al., 1999; Kim et al., 1997) . For example, the cytokines TNFa and IL6 are required for cell cycle progression early after hepatectomy (Cressman et al., 1996; Akerman et al., 1992; Yamada et al., 1997) . As IL6 stimulates genes involved in matrix modulation (Roeb et al., 1993) , this mechanism may change the assembly of the extracellular matrix, which might be growth inhibitory in normal liver architecture. A missing modulation of the extracellular matrix might explain why DNA synthesis could not be further increased in the Ras 61L group early after hepatectomy.
At present it cannot be completely excluded that paracrine mechanisms induced by transgene expression in non-parenchymal cells did occur. However the anity of adenoviruses towards hepatocytes is much stronger than towards non-parenchymal cells (DA Brenner, unpublished data) and therefore it is more likely that our observations are directly linked to ERK activation in hepatocytes.
In our present study we investigated the molecular mechanisms which link dominant-active Ras to cell cycle progression after hepatectomy. As cyclin E expression and less prominent DNA synthesis were increased through dominant-active Ras our results represent a ®rst step towards possible therapeutic approaches for increasing the proliferative response after hepatectomy. In further experiments additional factors, which either are required to induce full DNA synthesis ± e.g. c-myc ± or are essential for modulating the extracellular matrix should be de®ned. Our experimental approach provides a new means to increase the proliferative response of hepatocytes early after liver injury.
Materials and methods
Adenoviral constructs
JR Nevins, Department of Genetics, Duke University, North Carolina kindly provided the Ras 61L and RAS N17 adenoviruses (adv). The adv dl309 was a generous gift of Dr Adrian, Department of Virology, Medizinische Hochschule Hannover, Germany. The adv b-gal construct has been described before (Bradham et al., 1998) .
Adenovirus preparation
To generate high titer viral stocks, 2610 8 293 packaging cells at 90% con¯uence were infected at a multiplicity of infection (MOI) of 5 ± 10 Pfu per cell. The infected cells were cultured for 3 ± 5 days until a strong cytopathic eect could be observed and about 50% of these cells were detached. The cells were then collected by centrifugation and viral particles were released by four cycles of freezing in liquid nitrogen and rapid thawing at 378C. For further puri®cation the virus preparation was subjected to a twofold CsCl 2 banding. CsCl 2 banding and determination of infectivity by viral plaquing were performed according to protocols previously described (Becker et al., 1994) Endotoxin contaminations were monitored by the LAL-test kit (Chromogenix) following the protocol provided by the manufacturer. All virus preparations used for infection experiments and luciferase assays were LPS free. Virus preparations were stored at 7208C in 25% glycerol, 10 mM Tris/HCl, pH 7.4, and 1 mM MgCl 2 , 140 mM NaCl.
Cell culture, transfection experiments and luciferase assays
HepG2 cells were cultured in DMEM supplemented with 10% FCS. DNA transfection was performed using a modi®ed calcium phosphate precipitation method with an overnight incubation at 3% CO 2 and 358C as described previously (Niehof et al., 1997) . HepG2 were grown on 60 mm dishes to approximately 50% con¯uence when used for transfection experiments. By adding pBSK + DNA (Stratagene, USA) to 6 mg the total amount of DNA was kept constant in each transfection experiment. All transfections contained 0.2 mg of the b-galactosidase reporter pRSVbGal as an internal standard and 3 mg of the luciferase reporter gene construct. After transfection the cells were washed twice with phosphate-buered saline (PBS) and incubated in DMEM supplemented with 10% fetal bovine serum. After 4 h the cells were infected with adv Ras 61L, adv Ras N17 or adv dl309 at a multiplicity of infection of 100 for 24 h.
To measure luciferase activity cells were washed twice with phosphate-buered saline (PBS) and lysed by adding 350 ml extraction buer (25 mM Tris-H 3 PO 4 , pH 7.8, 2 mM EDTA, 10% (v/v) glycerol, 1% (v/v) Triton X-100 and 2 mM DTT) for 10 min. The lysates were cleared by centrifugation. Fifty ml of the supernatant were assayed by adding 300 ml measuring buer (25 mM glycylglycine, 15 mM MgSO 4 and 5 mM ATP). The light emission was measured in duplicate for 10 s in a Lumat LB 9501 (Berthold, Bad Wildbad, Germany) by injecting 100 ml 250 mM luciferin (Niehof et al., 1997) . Each experiment was performed in duplicate and repeated at least three times. Luciferase activity was normalized against b-galactosidase activity. The data show the speci®c luciferase activity and represent the average of three independent experiments.
For in-vitro infection experiments HepG2 cells were grown on 100 mm dishes to approximately 80% con¯uence and then infected with the dierent viral constructs at an MOl of 100 for 24 h. Cells were then washed twice in PBS, harvested and lysed in a NP-40 lysis buer (150 mM NaCl, 10 mM Tris/HCl, pH 7.4, 1 mM EDTA, 1% NP-40) to gain whole cell protein extracts.
Reporter gene constructs
The deletion reporter gene constructs of the Cyclin E promoter were kindly provided by P Jansen-DuÈ rr, Innsbruck, Austria (Botz et al., 1996) .
GST-cyclin E fusion construct
The cyclin E cDNA was cloned by nested-PCR from liver mRNA by using the primers: sense CCG AAT TCT GCC AAG GGA GAG AGA CTC GAC G and antisense GGG GTC GAC TTA GCA GCT TCT GGA GCA CTC AG (mouse Cyclin E: accession number No. X 75888; Damjanov et al., 1994) into the cloning vector Topo-TA (Invitrogen). The PCR product was veri®ed by sequencing. The Cyclin E cDNA insert was prepared by using the restriction sites EcoRI and Sall and cloned in frame into the vector pGEX-KG Glutagen TM plasmid. The resulting GST-cyclin E construct was used for protein expression in E. coli after induction with 0.5 mM IPTG. Quanti®cation of the fusion protein was performed by Coomassie blue staining. The speci®city of the protein was veri®ed by Western blot analysis using an anti-Cyclin E antibody.
Determination of transaminases
After a short spin at 200 g, plasma was recovered and stored at 7808C until it was used for the determination of aminotransferases. ALT and AST activities in plasma were determined by an automated enzyme assay as described before .
Two-thirds hepatectomy and preparation of nuclear extracts
Eight-week-old male NMRI mice with a weight between 20 to 25 g were obtained from the animal facility of the Medizinische Hochschule Hannover. The animals were maintained on a 12-h dark and 12-h light schedule. Twenty-four hours before surgery 1.6610 9 Pfu of the respective virus were injected per tail vein in 250 ml of the carrier solution (10 mM Tris/HCl, pH 7.4, 1 mM MgCl 2 , 140 mM NaCl).
Using increasing amounts of the b-gal virus the ecacy of hepatocyte infection and liver toxicity was tested. A dose of 1.6610 9 Pfu b-gal adenovirus (as tittered by plaques assay) infected at least 80% of the hepatocytes and did not result in a signi®cant increase in transaminases after 24 h. The reliability of the infection was controlled by X-galstained liver sections of adv b-gal infected livers. Transaminases were determined at each point of time after hepatectomy. For the HGF-experiments we used recombinant human HGF (Pepro-Tech, Inc.-USA, #100-39) dissolved in carrier solution in concentrations as indicated in Figure 7 .
Twelve hours before the surgery, food was withdrawn from the animals. Surgery was performed between 08.00 and 10.00 h. Animals were anesthetized by intraperitoneal injection of a combination of rompun/ketamine. After a small subxyphoid incision, two-thirds hepatectomy was performed as described by Higgins and Anderson (1931) . Following surgery a suture closed the abdominal cavum. Sham surgery was performed exactly as indicated for two-thirds hepatectomy, except that the liver was only manipulated and not resected.
For each time point indicated ®ve mice were used in parallel. Blood was drawn from the animals at each time point. The remaining livers were removed, pooled, rinsed in ice cold PBS and part of the livers were frozen immediately in liquid nitrogen or tissue-tek (Sakura Europe, Netherlands). The remaining liver was used to prepare nuclear extracts as described before . All the steps were performed at 48C.
SDS-polyacrylamide-gel electrophoresis and Western blot analysis
Nuclear extracts were separated on a 10% SDS-polyacrylamide gel and blotted onto a nitrocellulose membrane (Schleicher and Schuell) in 1% SDS, 20% Methanol, 400 mM glycine, 50 mM Tris-HCL, pH 8.3, at 48C for 2 h at 200 mA as described previously . Western blot analysis was performed as described before . For primary antibody incubation, membranes were probed with anti-ERK2 (Santa Cruz, USA, #Sc-153) anti-Cyclin A (Santa Cruz, USA, #Sc-751), antiCyclin E (Santa Cruz, USA, #Sc-481) or anti-Cyclin D1/2 (Upstate Biotechnology, USA, #05-362), anti-Phospho-p42/ 44 MAP kinase (Thr 202, Tyr 204) (New England Biolabs, #9101S), anti-Phospho-c-Jun, (Cell Signaling Technology, USA, #9261S) and anti-a-Tubulin (Santa Cruz, USA, #Sc-5546). As a secondary antibody, peroxidase-conjugated Donkey anti-rabbit IgG (Jackson Immuno Research Laboratories, Inc. USA, #711-035-152) was used. The antigenantibody complexes were visualized using the ECL detection system as recommended by the manufacturer (Amersham, Braunschweig, Germany). Western blot analysis was performed for each protein of interest at least three times.
Gel retardation assays
Gel shift experiments were performed as described before . Liver nuclear extracts were incubated with a 32P-labeled consensus E2F site in 16binding buer (25 mM HEPES, pH 7.6, 5 mM MgCl 2 , 34 mM KCL, 2 mM DTT, 0.2 mM PMSF, 1 mg/ml poly (dIdC), 2 mg/ml bovine serum albumin). 3.5 mg of liver nuclear extracts were incubated for 30 min on ice. Free DNA and DNA-protein complexes were resolved on a 4% TBEpolyacrylamide gel. For competition experiments, unlabeled (cold) consensus E2F oligonucleotide was added to the binding reaction.
BrdU labeling
For in vivo labeling, 30 mg/g mice of 5-bromo-2'-deoxyuridine (BrdU, Amersham, Braunschweig, Germany) were injected i.p. 2 h before sacri®cing. Liver tissue was frozen immediately in liquid nitrogen. To detect labeled nuclei, cryosections were prepared (5 mm thick). The tissue was ®xed in ice cold acetone/methanol and stained according to the Amersham cell proliferation kit manual (Amersham, Braunschweig, Germany).
Northern blot analysis
Northern blot analysis was performed according to standard procedures (Michalopoulos and DeFrances, 1997). The cyclin E and GAPDH cDNA probes were labeled with (a-P 32 ) ATP according to the Random priming protocol (Boehringer, Mannheim, Germany). The hybridization procedure was performed as described previously .
In vitro kinase assays ERK kinase assays ERK activity was assessed essentially as described before (Bradham et al., 1998) . Immunoprecipitation was performed with liver nuclear extracts using an anti-ERK 2 antibody and protein A agarose beads (Santa Cruz, C14; cross-reactive with ERK 1). The kinase reaction was performed in 50 ml kinase buer (20 mM HEPES (pH 7.5), 20 mM MgCl 2 , 20 mM Glycerolphosphat, 2 mM DTT) with 7.5 mg MBP and 5 mCi (g-P
32
) ATP. The proteins were fractionated using 12.5% SDS-polyacrylamide gel and visualized/quantitated using phospho imager analysis. Coomassie staining was used to demonstrate equal protein loading.
CDK2 kinase assay CDK2 activity was determined similarly as described for the ERK kinase assay. Immunoprecipitation was performed with 1 ml anti-CDK2 (Santa Cruz, USA, #Sc-163) in 15 mg of liver nuclear extracts for 0.5 h on ice. Forty ml protein A agarose beads were added for 1 h. After two washes in RIPA buer, CDK2 activity was determined by incubating 3 mg Histone H1 and 7 mCi (g-ATP
) ATP in kinase buer. The kinase reaction was stopped after 30 min with 36SDS sample buer and the proteins were separated using a 12.5% SDS-polyacrylamide gel. Visualization and quanti®cation was performed by phospho Imager analysis.
Cyclin E phosphorylation assay In the kinase reaction 5 mg of GST-Cyclin E bound to glutathione agarose were used as substrate. The fusion protein was incubated with 25 mg nuclear extracts in 30 ml kinase buer containing 5 mCi g-ATP 32 for 30 min at 308C. The kinase reaction was washed twice with HBB-buer (20 mM HEPES (pH 7.5), 50 mM NaCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 0.1% Triton X-100, 20 mM Glycerolphosphat, 1 mM DTT) and 36SDS sample buer was added. The proteins were separated using 12.5% SDS-polyacrylamide gel. Visualization and quanti®cation was performed by phospho Imager analysis.
